Abstracts

453 – MASH and the Progression of Cognitive Decline in Older People With HIV: A Prospective Study

Background Metabolic dysfunction-associated steatohepatitis (MASH), defined as steatosis with hepatocellular ballooning and lobular inflammation, is more common in people with HIV (PWH) and linked to systemic inflammation and extrahepatic complications, including cognitive impairment. We previously showed cross-sectional associations between MASH and poorer cognitive performance in older PWH. Here, we examined whether MASH predicts accelerated cognitive decline in…

259 – IL-6 Inhibits T-Cell Lineage Commitment of HSPCs During Pathogenic Retroviral Infection

Background Pathogenic retroviral infection, such as HIV/simian immunodeficiency virus (SIV), causes T cell lymphopenia. A fraction of people living with HIV, known as immunological nonresponders (INRs), present highly reduced thymic output despite complete viral suppression under therapy. The thymus, responsible for T cell regeneration, lacks autonomy in its ability to self-renew T cell committed progenitors,…

320 – Prior Immunity Continues to Protect Against Severe Mpox in 2025 Despite Time Since Vaccination

Background As the multinational mpox outbreak continues, ongoing transmission persists in the U.S. with recurrent clusters reported in 2025. Although vaccination and prior infection were associated with reduced severity early in the outbreak, the durability of this protection against severe disease remains uncertain. We evaluated disease severity among mpox cases diagnosed in 2025, focusing on…

241 – Neutrophil Extracellular Traps Impair Vaginal Barrier Function and Increase HIV Acquisition

Background The mucosal surface of the female genital tract (FGT) is comprised of physicochemical, immunological and microbial components that serve as frontline defense against sexually transmitted infections. Alterations of these components are associated with inflammation and higher HIV acquisition risk. Analysis from >700 women from the CAPRISA004 cohort show that women with a non-Lactobacillus dominant vaginal…

797 – The Pharmacokinetics and Safety of Doravirine in Pregnant Women Living With HIV and Their Infants

Background Vertical transmission of HIV remains a major challenge in low- and middle-income countries, compounded by rising NNRTI resistance. Doravirine, a second-generation NNRTI, has a favourable resistance profile, but data on safety and pharmacokinetics (PK) in pregnancy are limited. Methods DoraDO is an ongoing randomised, controlled, open-label study of 76 pregnant South African women initiating…

539 – Long-Term Effectiveness of Lenacapavir in Heavily Treatment-Experienced People With HIV-1 in the US

Background Lenacapavir (LEN) is a first-in-class capsid inhibitor indicated for the treatment of HIV-1 in heavily treatment-experienced (HTE) adults in combination with other antiretrovirals (ARVs) and for HIV-1 prevention. We describe real-world effectiveness of LEN across 18 months (M) in a US-based cohort and optimized background regimen (OBR) patterns pre- and post-LEN.  Methods We retrospectively examined…

551 – Env Mutations Are a Gateway for Acquisition of InSTI Resistance

Background Virological failure (VF) has been observed in people with HIV (PWH) receiving second-generation integrase (IN) strand transfer inhibitors (INSTIs) without IN resistance mutations. To elucidate alternative INSTI resistance mechanisms, we previously passaged HIV-1 in a T-cell line for ~1 year with escalating concentrations of the INSTI dolutegravir (DTG). HIV-1 developed resistance to DTG by…

281 – SOSIP Immunization Induces Neutralizing Antibodies to Diverse Clade B Strains in HIVAC-FOUND Trial

Background The induction of broadly neutralizing antibodies (bNAbs) remains a major challenge in the development of an effective preventive HIV vaccine. To target transmitted-founder (T/F) viruses, we designed a SOSIP protein based on an acutely infected individual who naturally developed bNAbs (“early neutralizer”) and evaluated this vaccine prototype in HIV-negative volunteers. Methods The HIVACFOUND study…

864 – Acquired HIV-1 Drug Resistance in Perinatal HIV

Background Children and adolescents with perinatal HIV have a high risk of development of drug resistance mutations (DRM). Acquisition of DRM is related to non-adherence and frequent treatment switches in this vulnerable population. This study aimed to assess the cumulative prevalence of DRM in young adults with perinatal HIV compared to matched individuals with horizontally…